Enzo Biochem Inc (ENZ) Com Stk USD0.01

Sell:$0.55Buy:$0.56$0.02 (2.61%)

Prices delayed by at least 15 minutes
Sell:$0.55
Buy:$0.56
Change:$0.02 (2.61%)
Prices delayed by at least 15 minutes
Sell:$0.55
Buy:$0.56
Change:$0.02 (2.61%)
Prices delayed by at least 15 minutes

Company Information

About this company

Enzo Biochem, Inc. is a global life science company. The Company's primary business is conducted through its Life Sciences division, Enzo Life Sciences, which is focused on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of products, including antibodies, genomic probes, assays, biochemicals, and proteins. Its products are used to label, detect and visualize a biological target of interest in drug discovery exploration and drug development process development. The Company’s proprietary products and technologies play central roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The Company monetizes its technology primarily via sales through its global distribution network and licensing. The Company conducts its research and other product development efforts through internal research and collaborative relationships.

Key people

Kara Cannon
Chief Executive Officer, Chief Operating Officer
Patricia Eckert
Chief Financial Officer
Brian Fisher
General Counsel, Secretary
Steven J. Pully
Non-Executive Independent Chairman of the Board
Jonathan M. Couchman
Independent Director
Bradley L. Radoff
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US2941001024
  • Market cap
    $30.75m
  • Employees
    125
  • Shares in issue
    52.24m
  • Exchange
    New York Stock Exchange
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.